The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin

Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel

(2013) Hao Wu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Prognostic Value of Survivin in Patients with Gastric Cancer: A Systematic Review with Meta-Analysis

(2013) Jin Long Liu et al.   PLoS One

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The role of Tau protein in resistance to paclitaxel

(2011) Marta Smoter et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay

(2010) Chun-Jian Qi et al.   ARCHIVES OF PHARMACAL RESEARCH

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy

(2010) S Glaysher et al.   BRITISH JOURNAL OF CANCER

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)

(2009) Sharon Glaysher et al.   BMC CANCER

Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance

(2009) J. Lu et al.   CLINICAL CANCER RESEARCH

Cell Cycle Checkpoint Models for Cellular Pharmacology of Paclitaxel and Platinum Drugs

(2008) Ardith W. El-Kareh et al.   AAPS Journal